HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Keler Selected Research

Ovarian Neoplasms (Ovarian Cancer)

12/2021A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Keler Research Topics

Disease

6Neoplasms (Cancer)
12/2021 - 06/2000
2Neonatal Alloimmune Thrombocytopenia
02/2003 - 12/2000
1Ovarian Neoplasms (Ovarian Cancer)
12/2021
1Autoimmune Diseases (Autoimmune Disease)
12/2001
1Lymphoma (Lymphomas)
02/2001
1Adenocarcinoma
02/2001
1Breast Neoplasms (Breast Cancer)
06/2000

Drug/Important Bio-Agent (IBA)

3VaccinesIBA
12/2021 - 12/2001
3Immunoglobulin G (IgG)IBA
02/2001 - 12/2000
2AntibodiesIBA
05/2007 - 02/2003
2CytokinesIBA
02/2001 - 06/2000
2Fc Receptors (Fc Receptor)IBA
02/2001 - 02/2001
1Immune Checkpoint InhibitorsIBA
12/2021
1Cancer VaccinesIBA
12/2021
1AntigensIBA
02/2012
1Proteins (Proteins, Gene)FDA Link
02/2012
1human ITGB3 protein (HPA-1a)IBA
02/2003
1MDX-H210 antibodyIBA
02/2001
1EnzymesIBA
02/2001
1Immunoglobulin A (IgA)IBA
02/2001
1Superoxides (Superoxide)IBA
02/2001
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
06/2000
1Macrophage Colony-Stimulating FactorIBA
06/2000
1IgG Receptors (Fc gamma RI)IBA
06/2000
1Fc(alpha) receptorIBA
06/2000

Therapy/Procedure

4Therapeutics
12/2021 - 06/2000
1Immunotherapy
12/2021